Arcus Biosciences (RCUS) PT Raised to $45 at Mizuho
Tweet Send to a Friend
Mizuho analyst Mara Goldstein raised the price target on Arcus Biosciences (NYSE: RCUS) to $45.00 (from $42.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
